ATE191928T1 - Zellzyklus- kontrollzusammensetzungen und methoden diese zu benutzen. - Google Patents

Zellzyklus- kontrollzusammensetzungen und methoden diese zu benutzen.

Info

Publication number
ATE191928T1
ATE191928T1 AT92924108T AT92924108T ATE191928T1 AT E191928 T1 ATE191928 T1 AT E191928T1 AT 92924108 T AT92924108 T AT 92924108T AT 92924108 T AT92924108 T AT 92924108T AT E191928 T1 ATE191928 T1 AT E191928T1
Authority
AT
Austria
Prior art keywords
cell cycle
cell
methods
cycle control
protein
Prior art date
Application number
AT92924108T
Other languages
English (en)
Inventor
Wen-Hwa Lee
Eva Y H P Lee
David W Goodrich
Nang-Ping Wang
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE191928T1 publication Critical patent/ATE191928T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92924108T 1991-10-17 1992-10-16 Zellzyklus- kontrollzusammensetzungen und methoden diese zu benutzen. ATE191928T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77851091A 1991-10-17 1991-10-17
PCT/US1992/008918 WO1993008267A1 (en) 1991-10-17 1992-10-16 Cell cycle controlling compositions and methods of using same

Publications (1)

Publication Number Publication Date
ATE191928T1 true ATE191928T1 (de) 2000-05-15

Family

ID=25113590

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92924108T ATE191928T1 (de) 1991-10-17 1992-10-16 Zellzyklus- kontrollzusammensetzungen und methoden diese zu benutzen.

Country Status (11)

Country Link
EP (1) EP0610420B1 (de)
JP (2) JP3450006B2 (de)
KR (1) KR100279797B1 (de)
AT (1) ATE191928T1 (de)
AU (1) AU679431B2 (de)
CA (1) CA2120353C (de)
DE (1) DE69230943T2 (de)
ES (1) ES2148181T3 (de)
NO (1) NO315895B1 (de)
TW (1) TW346397B (de)
WO (1) WO1993008267A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0666312A1 (de) * 1994-02-08 1995-08-09 Wolfgang A. Renner Verfahren zur Förderung des Wachstums von Säugetierzellen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341576C (en) * 1986-08-11 2008-07-08 Thaddeus P. Dryja Diagnosis of retinoblastoma
US4942123A (en) 1987-09-17 1990-07-17 The Regents Of The University Of California ppRB110 -phosphoprotein the retinoblastoma susceptibility gene product
JP3163090B2 (ja) * 1988-01-21 2001-05-08 マサチューセッツ アイ アンド イヤー インファーマリー 網膜芽腫診断剤
ATE161039T1 (de) 1988-10-31 1997-12-15 Univ California Erzeugnisse und verfahren zur regelung der suppression von neoplastischen phenotypen
ZA909755B (en) * 1989-12-07 1991-09-25 Res Dev Foundation Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product

Also Published As

Publication number Publication date
CA2120353A1 (en) 1993-04-29
JP3450006B2 (ja) 2003-09-22
AU679431B2 (en) 1997-07-03
DE69230943T2 (de) 2000-11-30
DE69230943D1 (de) 2000-05-25
EP0610420B1 (de) 2000-04-19
NO941377D0 (no) 1994-04-15
JPH07504805A (ja) 1995-06-01
NO315895B1 (no) 2003-11-10
WO1993008267A1 (en) 1993-04-29
EP0610420A1 (de) 1994-08-17
NO941377L (no) 1994-06-10
KR100279797B1 (ko) 2001-04-02
TW346397B (en) 1998-12-01
CA2120353C (en) 2008-04-29
JP2003277290A (ja) 2003-10-02
ES2148181T3 (es) 2000-10-16
AU3054692A (en) 1993-05-21

Similar Documents

Publication Publication Date Title
DE69530196D1 (de) Methode zum verhindern der aggregation von proteinen/peptiden bei rehydratation oder auftauen
BR9608114A (pt) Vacinas de pertussis a celular e processos para preparação das mesmas
ATE43635T1 (de) Verfahren zur herstellung von interferon und expressionsvektoren dafuer.
FI940932A0 (fi) Koostumuksia ja menetelmiä haavojen hoitamiseksi
EP0377836A3 (de) Verfahren und Mittel zur Haarpflege
DE69230789D1 (de) Methoden zur behandlung von durch den tumor nekrose faktor ausgelösten krankheiten
ATE159429T1 (de) Methode zum überbringen von agenzien an zielzellen
DE69525151D1 (de) Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
DK322188A (da) Fremgangsmaade til fremstilling af protein
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
DE69101634D1 (de) Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus.
ES450208A1 (es) Un metodo de preparacion de una gamma-globulina anti-hbs a partir de plasma humano.
EP0009206A3 (en) Fluor-containing 1,4-dihydropyridines, process for their preparation and their application in pharmaceuticals
EP0751954A4 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
DK0419878T3 (da) Nye aprotinin-varianter og genteknologisk fremgangsmåde til mikrobiel fremstilling af disse varianter i homogent processeret form
DE69230943D1 (de) Zellzyklus- Kontrollzusammensetzungen und Methoden diese zu benutzen.
ATE178206T1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
BG101125A (en) Low molecular biologically active substance of yeasts and method for its preparation
BR8306027A (pt) Composto;composicao e metodo apropriado para o controle do crescimento de vegetacao indesejada
DK0658117T3 (da) Behandling af tumorer med neurotrofe faktorer og celleproliferationsinhibitorer
DE69615685D1 (de) Impstoff gegen krankheitserreger, zusammensetzung zur behandlung und vorbeugung von hiv infektionen
NO940406L (no) Preparat og fremgangsmåte for behandling av sårskader
EP0195087A4 (de) Zyklische doppelsträngige dns, deren h2rstellung, mikroorganismen, die diese enthalten, verfahren zur herstellung von einer antigen-determinanten stelle des poliovirus-kapsids aufweisenden proteins und protein-vp1 unter verwendung derselben.
ATE163344T1 (de) Zusammensetzungen zur behandlung von geernteter pflanzenmaterial
JPS5218827A (en) Soil-treating agents for the control of white ants and method of apply ing the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties